2025-07-01 13:51:15.AIbase.19.4k
Chai-2 Makes a Shocking Debut: AI-Powered Zero-Shot Antibody Design, Accelerating Drug Development by Hundreds of Times
Artificial intelligence once again stirs up the field of drug development! Chai Discovery recently launched a new AI model called Chai-2, which has drawn widespread attention with its breakthrough technology in molecular design. Chai-2 achieves zero-shot antibody design with a success rate of 16%-20%, hundreds of times higher than traditional methods, shortening the drug development cycle from months or even years to just two weeks. Zero-shot antibody design breaks through traditional bottlenecks. Chai-2 is a multi-modal generative AI model developed by Chai Discovery, specifically designed for...